Valganciclovir versus valacyclovir prophylaxis for prevention of cytomegalovirus: an economic perspective

Publisher： John Wiley & Sons Inc

E-ISSN： 1399-3062|17|3|334-341

ISSN： 1398-2273

Source： TRANSPLANT INFECTIOUS DISEASE (ELECTRONIC), Vol.17, Iss.3, 2015-06, pp. : 334-341

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Low‐dose valganciclovir prophylaxis for cytomegalovirus in intermediate‐risk (R+) renal transplant recipients: Single‐center experience

By  

TRANSPLANT INFECTIOUS DISEASE (ELECTRONIC), Vol. 19, Iss. 6, 2017-12 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Response to: lower‐dose valganciclovir for prevention of cytomegalovirus after solid organ transplant: an important tradeoff

By  

TRANSPLANT INFECTIOUS DISEASE (ELECTRONIC), Vol. 17, Iss. 4, 2015-08 ,pp. : 625-626

John Wiley & Sons Inc

Access to resources Recommend Favorite

Lower‐dose valganciclovir for the prevention of cytomegalovirus after solid organ transplantation: an important tradeoff

By  

TRANSPLANT INFECTIOUS DISEASE (ELECTRONIC), Vol. 17, Iss. 4, 2015-08 ,pp. : 623-624

John Wiley & Sons Inc

Access to resources Recommend Favorite

Increased risk of breakthrough infection among cytomegalovirus donor‐positive/recipient‐negative kidney transplant recipients receiving lower‐dose valganciclovir prophylaxis

By  

TRANSPLANT INFECTIOUS DISEASE (ELECTRONIC), Vol. 17, Iss. 2, 2015-04 ,pp. : 163-173

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cytomegalovirus post kidney transplantation: prophylaxis versus pre‐emptive therapy?

By  

TRANSPLANT INTERNATIONAL (ELECTRONIC), Vol. 28, Iss. 12, 2015-12 ,pp. : 1351-1356

John Wiley & Sons Inc

Access to resources Recommend Favorite